bioRxivCancer BiologyPreprint
Caspase-resistant ROCK1 expression prolongs survival of E-mu-Myc B cell lymphoma mice.
K. Mardilovich, G. Naylor, L. Julian, N. Phinichkusolchit, K. Keeshan, K. Blyth, M. F. Olson
Abstract
Apoptosis is characterized by membrane blebbing and apoptotic body formation. Caspase cleavage of ROCK1 generates an active fragment that promotes actin-myosin mediated contraction and membrane blebbing during apoptosis. Expression of caspase-resistant non-cleavable ROCK1 (Rock1 NC) prolonged survival of mice that rapidly develop B cell lymphomas due to E{micro}-Myc transgene expression. E{micro}-Myc; Rock1 NC mice had significantly fewer bone marrow cells relative to E{micro}-Myc mice expressing wild-type ROCK1 (Rock1 WT), which was associated with altered cell cycle profiles. Circulating macrophage numbers were lower in E{micro}-Myc; Rock1 NC mice, but there were higher levels of bone marrow macrophages, consistent with spontaneous cell death in E{micro}-Myc; Rock1 NC mice bone marrows being more inflammatory. Rock1 WT recipient mice transplanted with pre-neoplastic E{micro}-Myc; Rock1 NC bone marrow cells survived longer than mice transplanted with E{micro}-Myc; Rock1 WT cells, indicating that the survival benefit was intrinsic to the E{micro}-Myc; Rock1 NC bone marrow cells. The results suggest that the apoptotic death of E{micro}-Myc; Rock1 NC cells generates a proliferation-suppressive microenvironment in bone marrows that reduces cell numbers and prolongs B cell lymphoma mouse survival.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Immunogenic cell death in mice expressing caspase-resistant ROCK1 is not replicated by ROCK inhibitors
G. Naylor, L. Julian, … M. F. Olson·bioRxiv·Apr 14, 2022
- MNT loss in MYC-driven B lymphoma cells enhances apoptosis, inhibits proliferation and increases sensitivity to cancer drugs.
Hai Vu Nguyen, Marcel Michla, … Suzanne Cory·bioRxiv·May 1, 2026
- mTORC1 activity is essential for disease progression in chronic lymphocytic leukemia
N. Malik, J. Hay, … A. M. Michie·bioRxiv·Apr 19, 2022
- Cell circuits between leukemic cells and mesenchymal stem cells block lymphopoiesis by activating lymphotoxin-beta receptor signaling
X. Feng, R. Sun, … J. P. Pereira·bioRxiv·Sep 23, 2022
- MYC Functions as a Switch for Natural Killer Cell-Mediated Immune Surveillance of Lymphoid Malignancies
S. Swaminathan, L. Heftdal, … D. Felsher·bioRxiv·Dec 28, 2018
- Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
M. Herold, M. A. Potts, … A. Strasser·Cell Death & DifferentiationPeer-reviewed·Jun 1, 2023